UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000047293
Receipt number R000053866
Scientific Title Retrospective observational study on the effect of rehabilitation during hospitalization on severely COVID-19 patients
Date of disclosure of the study information 2022/04/01
Last modified on 2025/09/27 14:28:41

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of rehabilitation during hospitalization for severely COVID-19 patients

Acronym

Effects of Rehabilitation on severely COVID-19

Scientific Title

Retrospective observational study on the effect of rehabilitation during hospitalization on severely COVID-19 patients

Scientific Title:Acronym

Effects of Rehabilitation on severely COVID-19

Region

Japan


Condition

Condition

Severely COVID-19 patients

Classification by specialty

Pneumology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to investigate the effect of rehabilitation during hospitalization on severely COVID-19 patients in Japan.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Physical function: MRC score, Short physical performance battery (SPPB)
ADL: Intensive Care Unit Mobility Scale, Barthel index, functional status score for the ICU

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

100 years-old >

Gender

Male and Female

Key inclusion criteria

1. Patients diagnosed with COVID-19
2. Patients over 18 years old
3. Japanese nationals

Key exclusion criteria

1. Patients residing outside the country
2. Patients who have COVID-19 but whose reason for hospitalization is not COVID-19
3. Patients deemed inappropriate as subjects for this study by the principal investigator

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Shuhei
Middle name
Last name Yamamoto

Organization

Shinshu University Hospital

Division name

Department of Rehabilitation

Zip code

390-8621

Address

3-1-1 Asahi, Matsumoto-shi, Nagano, Japan, 390-8621

TEL

0263372836

Email

syamamoto@shinshu-u.ac.jp


Public contact

Name of contact person

1st name Shuhei
Middle name
Last name Yamamoto

Organization

Shinshu University Hospital

Division name

Department of Rehabilitation

Zip code

390-8621

Address

3-1-1 Asahi, Matsumoto-shi, Nagano, Japan, 390-8621

TEL

0263372836

Homepage URL


Email

syamamoto@shinshu-u.ac.jp


Sponsor or person

Institute

Shinshu University Hospital

Institute

Department

Personal name



Funding Source

Organization

self-procurement

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Shinshu University Hospital

Address

3-1-1 Asahi, Matsumoto-shi, Nagano, Japan, 390-8621

Tel

0263372836

Email

syamamoto@shinshu-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 04 Month 01 Day


Related information

URL releasing protocol

https://center6.umin.ac.jp/cgi-open-bin/ctr/ctr.cgi?function=brows&action=brows&recptno=R000053866&t

Publication of results

Published


Result

URL related to results and publications

https://www.mdpi.com/2077-0383/11/21/6578

Number of participants that the trial has enrolled

23

Results

The median age of the total 23 patients was 59 years, 73.9% were male, and the median PaO2/FiO2 at admission was 172.0. All physical function and ADL parameters were significantly improved from the time of admission to discharge. Moreover, SPPB at discharge significantly correlated with WBC, C-reactive protein, and a significant trend with PaO2/FiO2 and age. Although the median Barthel index at dis-charge was 90 points, 47% of patients had sarcopenia as defined by an SPPB of <9 points.

Results date posted

2025 Year 09 Month 27 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Moderate to severe COVID-19 patients, who had PaO2 below 60 mmHg without oxygen and required ICU management, were admitted to Shinshu University Hospital. As our institution is a tertiary care hospital, all patients are those who are determined to be difficult to manage intensively in secondary care. All patients with COVID-19 had a positive PCR test result for SARS-CoV-2. After admission, the patients were first examined by a rehabilitation physician, followed by respiratory rehabilitation intervention by rehabilitation staff, specifically physical and occupational therapists with expertise in the respiratory system.

Participant flow

A total of 23 patients with COVID-19 were included from February 2020 to September 2021. Among 26 patients enrolled in this study, 23 (88.5%) fulfilled the inclusion criteria and received intensive treatment in the ICU.

Adverse events

In this study, no adverse events such as unplanned extubation, accidental arterial catheter or feeding tube removal, uncontrolled arrhythmia, and falls occurred during physio-therapy. Six patients (26.1%) had desaturation of SpO2 >4% at baseline, and one patient (4.5%) had orthostatic hypotension of SBP >20 mmHg at baseline during rehabilitation. Infection control for COVID-19 among physical therapists is also an important issue, and none of the physical therapists working in the COVID-19 ward were SARS-CoV-2-positive during the study period.

Outcome measures

Rehabilitation staff evaluated the following physical functions and ADLs at hospital admission and discharge:

1. Physical functions
We evaluated the Medical Research Council (MRC) score and short physical performance battery (SPPB) as markers of physical function. The MRC score is a muscle strength assessment with a score of 5 points for shoulder abduction, elbow flexion, wrist dorsiflexion, hip flexion, knee extension, and ankle dorsiflexion, with a total score of 60 points. The SPPB is a multidomain performance assessment that consists of three domains, viz., balance test, standing test, and 4m walk test. Each domain is evaluated on a scale of 4 points, with a total of 12 points.

2. ADLs
The intensive care unit mobility scale (IMS), functional status score for the ICU (FSSICU), and Barthel index were evaluated as indicators of ADLs. The IMS is a simple scale that evaluates ADLs from lying in bed to walking in 10 categories, based on whether the patient is able to do so or not. The FSSICU is a scale that evaluates five domains from turning over to walking on a scale of 7 points depending on the amount of assistance, with a total of 35 points. The Barthel index is a scale that evaluates basic ADLs such as eating, dressing, toileting activities, and bathing according to the amount of assistance, with a total score of 100 points.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2022 Year 04 Month 01 Day

Date of IRB

2022 Year 04 Month 13 Day

Anticipated trial start date

2022 Year 04 Month 01 Day

Last follow-up date

2023 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

retrospective observational study


Management information

Registered date

2022 Year 03 Month 26 Day

Last modified on

2025 Year 09 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053866